EHAB - Enhabit - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29332G1022
Home Health, Hospice Services
Enhabit, Inc. is a leading provider of home health and hospice services in the United States, dedicated to delivering high-quality care to patients in the comfort of their own homes.
The company's comprehensive home health services encompass a wide range of medical and therapeutic care, including patient education, pain management, wound care, and infusion therapy, as well as skilled observation and assessment services. Additionally, Enhabit's healthcare professionals develop personalized plans to manage chronic diseases and conditions, such as diabetes, hypertension, arthritis, and Alzheimer's disease, among others. The company's therapy services, provided by physical, occupational, and speech therapists, aim to improve patients' mobility, functionality, and overall well-being.
In addition to home health services, Enhabit offers hospice care, focusing on providing comfort and support to terminally ill patients and their families. The company's hospice services include pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling, addressing the physical, emotional, spiritual, and psychosocial needs of patients and their loved ones.
With a rich history dating back to 1998, Enhabit, Inc. is headquartered in Dallas, Texas, and has undergone a significant transformation, rebranding from Encompass Health Home Health Holdings, Inc. to Enhabit, Inc. in March 2022. Today, the company remains committed to its mission of delivering compassionate, patient-centered care to those who need it most.
For more information about Enhabit, Inc. and its services, please visit their website at https://www.ehab.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
EHAB Stock Overview
Market Cap in USD | 376m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC SubIndustry | Health Care Services |
TER | 0.00% |
IPO / Inception | 2022-07-01 |
EHAB Stock Ratings
Growth 5y | -70.5 |
Fundamental | -35.3 |
Dividend | 0.00 |
Rel. Performance vs Sector | -2.48 |
Analysts | 3.00/5 |
Fair Price Momentum | 5.66 USD |
Fair Price DCF | 14.74 USD |
EHAB Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
EHAB Growth Ratios
Growth 12m | -8.88% |
Growth Correlation 12m | -54.2% |
Growth Correlation 3m | -91.7% |
CAGR 5y | -41.40% |
CAGR/Mean DD 5y | -0.79 |
Sharpe Ratio 12m | -0.24 |
Alpha vs SP500 12m | -29.28 |
Beta vs SP500 5y weekly | 0.44 |
ValueRay RSI | 28.91 |
Volatility GJR Garch 1y | 54.98% |
Price / SMA 50 | -8.77% |
Price / SMA 200 | -22.38% |
Current Volume | 282.5k |
Average Volume 20d | 407.8k |
External Links for EHAB Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 22, 2024, the stock is trading at USD 7.18 with a total of 282,527 shares traded.
Over the past week, the price has changed by +0.28%, over one month by -10.81%, over three months by -25.52% and over the past year by -9.91%.
According to ValueRays Forecast Model, EHAB Enhabit will be worth about 6.1 in October 2025. The stock is currently trading at 7.18. This means that the stock has a potential downside of -14.76%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 9.2 | 28.3 |
Analysts Target Price | 11.1 | 54.3 |
ValueRay Target Price | 6.1 | -14.8 |